VIVIMEDLAB Share Price Performance
₹5.79
-20.81 (-78.23%)
Price ₹5.79
Share Pricen/a
Vivimed Labs Limited's (NSE:VIVIMEDLAB) 31% Dip In Price Shows Sentiment Is Matching Revenues
Feb 09
Vivimed Labs Limited Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
VIVIMEDLAB Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Vivimed Labs Limited Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
- -4.22
- 54.72%
- -39.54%
- -800.7%
About VIVIMEDLAB
- Founded
- 1988
- Employees
- 586
- CEO
- WebsiteView website
Vivimed Labs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, specialty chemicals, and retail branded formulations in India. It operates through two segments, Speciality Chemicals Business and Pharma Business. The company provides APIs and intermediates to generic and ethical companies; and branded formulations in therapeutic segments, such as ophthalmic, nutraceuticals, dermatology, and pain, as well as contract manufacturing of capsules and tablets, syrups and liquids, and nasal sprays and ointments. It also exports its products. The company was incorporated in 1988 and is based in Hyderabad, India.
